Spots Global Cancer Trial Database for Shared Healthcare Actions and Reflections Electronic Systems in Survivorship

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Shared Healthcare Actions and Reflections Electronic Systems in Survivorship

Official Title: SHARE-S Aim 3: Shared Healthcare Actions & Reflections Electronic Systems in Survivorship

Study ID: NCT04337203

Conditions

Cancer

Survivorship

Hematopoietic and Lymphoid Cell Neoplasm

Malignant Solid Neoplasm

Interventions

SHARE-S Implementation Program

Study Description

Brief Summary: The primary purpose of this study is conduct a pilot study testing the study protocols, implementation program, and mixed-methods data collection.

Detailed Description: Primary Objectives: • To evaluate how successfully SHARE-S can be implemented into clinical care as characterized by rates of enrollment. Investigators hypothesize \>30% of patients e-referred to SHARE-S will enroll. Secondary Objectives: * To assess additional implementation outcomes that evaluate preliminary implementation success (i.e., further assessment of adoption, acceptability, appropriateness, further assessment of feasibility, and fidelity). * To describe service outcome variability to inform future studies. Investigators will assess service outcomes relevant to Commission on Cancer requirements by reporting annual estimates for: (1) the estimated number of patients impacted by SHARE-S; (2) the cancer sites impacted by SHARE-S; and the (3) resources/processes utilized to enhance each of the chosen services if barriers were encountered. We will also assess safety and perceived patient-centeredness of care. * To describe patient health outcome variability to inform future studies (i.e., social role, physical functioning, anxiety, depression, fatigue, sleep disturbance, pain, cancer-specific quality of life, health behaviors, patient autonomy, self-efficacy for managing cancer, engagement with the survivorship care plan document, and satisfaction with care). * To evaluate the Implementation Program we will assess key milestones and processes for this pilot study of the Implementation Stage measured at the clinic level. * To qualitatively assess implementation barriers and facilitators using semi-structured interviews that will be audio-recorded. * To examine how study results vary by cancer type.